Kala Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $79,657.83 +4.31%
Ethereum $3,201.51 +5.46%
BNB $636.00 +1.83%
Optimism $1.70 +5.47%
Arbitrum $0.64 +6.42%
Solana $205.52 +2.57%
Polygon $0.41 +7.30%
Cosmos $5.43 +15.29%
Avalanche $32.41 +11.22%

Bitcoin $79,657.83 +4.31%
Ethereum $3,201.51 +5.46%
BNB $636.00 +1.83%
Optimism $1.70 +5.47%
Arbitrum $0.64 +6.42%
Solana $205.52 +2.57%
Polygon $0.41 +7.30%
Cosmos $5.43 +15.29%
Avalanche $32.41 +11.22%

Kala Pharmaceuticals

company

Funding Rounds

Number of Funding Rounds

Total Funding Amount

13

$627.36M

Kala Pharmaceuticals has raised a total of $627.36M in funding over 2 rounds. Their latest funding was raised on Nov 28, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 28, 2022	Post-IPO Equity	$31M	—	—	—	Detail
Nov 29, 2021	Post-IPO Equity	$16.12M	—	—	—	Detail
May 12, 2021	Post-IPO Debt	$125M	1	Oxford Finance LLC	—	Detail
Apr 6, 2020	Post-IPO Equity	$134M	—	—	—	Detail
Oct 3, 2018	Post-IPO Equity	$110M	1	Athyrium Capital Management LP	—	Detail
Jul 20, 2017	IPO	$90M	—	—	—	Detail
Apr 13, 2016	Series C	$68M	8	Longitude Capital	—	Detail
Aug 17, 2015	Series Unknown	$6.99M	—	—	—	Detail
Apr 23, 2014	Series B	$22.50M	6	Ysios Capital	—	Detail
Feb 28, 2013	Series A	$11.50M	4	Crown Venture Fund	—	Detail
Mar 14, 2012	Private Equity（PE）	$7.24M	4	—	—	Detail
Nov 10, 2010	Series Unknown	$3M	—	—	—	Detail
Dec 24, 2009	Series A	$2M	—	—	—	Detail